Martin Berger
About
In The Last Decade
Martin Berger
33 papers receiving 714 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 248
- Oncology 154
- Pathology and Forensic Medicine 150
- Surgery 127
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Martin Berger
This map shows the geographic impact of Martin Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Berger more than expected).
Fields of papers citing papers by Martin Berger
This network shows the impact of papers produced by Martin Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Berger. The network helps show where Martin Berger may publish in the future.
Co-authorship network of co-authors of Martin Berger
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Berger. A scholar is included among the top collaborators of Martin Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Berger. Martin Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 53 | |
| 10 | 29 | |
| 11 | 4 | |
| 12 | Strategien kleinerer europäischer Staaten in der Technologiepolitik als Antwort auf die Herausforderung durch China und Indien: die Entwicklung von Strategien in Finnland, Schweden, der Schweiz und den Niederlanden, mit einem Anhang zur F&E-Politik der Europäischen Union | 0 |
| 13 | 32 | |
| 14 | Identification and characterization of riproximin, a new type II ribosome-inactivating protein with potent anticancer activity, from aqueous Ximenia americana extracts used by African traditional medicine | 4 |
| 15 | 43 | |
| 16 | 144 | |
| 17 | 16 | |
| 18 | 23 | |
| 19 | 189 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.